Overview
Medventure Spółka Z Ograniczoną Odpowiedzialnością Alternatywna Spółka Inwestycyjna is a venture capital fund that invests in research and development projects in the MedTech sector, focusing on areas such as telemedicine systems, AI algorithms for medical decision support, disease diagnosis, and modern drugs and vaccines. The fund has an investment budget of 40 million PLN and provides extensive support, including know-how and contacts, to help develop projects with global market potential.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 24, 2026 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
General partners
Manner of representation
The general partner has the right to represent the company individually, including performing all judicial and extrajudicial acts. The sole general partner of the company is MEDVENTURE limited liability company with its registered office in Lublin, in which: in the case of a one-person management board, the President of the Management Board is authorised to make declarations on behalf of the company; in the case of a two-person management board, two members of the management board acting jointly are authorised to make declarations of will; in the case of a three-person management board, two members of the management board acting jointly are authorised to make declarations on behalf of the company; in the case of a four-person management board, three members of the management board acting jointly are authorised to make declarations on behalf of the company.
Beneficial owners
| Person | Rights |
|---|---|
Marcin Kopyś (48)  | Shareholder in a limited joint-stock partnership, 48.9% |
Tomasz Marcin Piwoński (46) | Shareholder in a limited joint-stock partnership, 22.28%; Sprawuje kontrole nad spółkami posiadającymi łącznie 18,80% akcji w spółce zgłaszanej |
Subsidiaries
| Name | Share value | Stake | |
|---|---|---|---|
Woundscanningsp. z o.o. | 459.21 USD | 25.3731% | |
Content+sp. z o.o. | 1,080.50 USD | 40% | |
PRP Analyticssp. z o.o. | 540.25 USD | 20% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| INC Private EquityS.A. | $147,510.97 | incpeasi.pl | |
| Movens Venture CapitalS.K.A. | $126,417.00 | movenscapital.com | |
| Fundingbox Deep Tech FundS.K.A. | $131,737.32 | fundingbox.vc | |
| Carlson Asi Evig AlfaS.K.A. | $123,331.74 | evigalfa.pl | |
| Knowledgehub StarterS.K.A. | $103,567.76 | kh.vc | |
| I TeamvestS.K.A. | $84,724.70 | teamvestcapital.com | |
| Xplorer Fund AsiS.A. | $84,145.82 | xplorerfund.com | |
| Impera Alfasp. z o.o. | $73,176.92 | imperaalfa.pl | |
| Kogito VenturesS.K.A. | $41,821.28 | kogito-ventures.com | |
| Smok VenturesS.K.A. | $40,470.43 | smok.vc |
Change history
| Date | Event |
|---|---|
| 2026-07-31 | Share capital change (167,972.00 PLN → 166,734.00 PLN) |
| 2026-04-22 | Name change (Medventure Spółka Z Ograniczoną Odpowiedzialnością Alternatywna Spółka Inwestycyjna → Medventure) |
| 2026-04-22 | PKD change (Removed: 64.30.Z; Added: 64.21.Z, 70.20.Z) |
| 2024-05-14 | Share capital change (147,121.00 PLN → 167,972.00 PLN) |
| 2024-03-26 | Share capital change (124,062.00 PLN → 147,121.00 PLN) |
FAQ
Last updated: 2026-08-19